John McKendry, President and CEO of KYE, gives insights into the importance of operating within regulations, leadership in pharma, and new treatment and delivery options for ADHD.
S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment
healthbiz.substack.com
National Pharmaceutical Congress (NPC) Podcast
Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.
Created in response to industry requests, NPC Podcast hosts Jim Shea, Mark McElwain and Mitch Shannon interview an esteemed series of guests with pertinent questions about the pharma industry.Listen on
Substack App
Spotify
RSS Feed
Appears in episode
Jeremy Visser
Recent Episodes
S13 E01 Small Company, Seismic Impact: KYE Pharmaceuticals Redefines ADHD Treatment